WILLIAM ENGSTROM: Open Payments
NPI 1437153954 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 17 payments from 7 companies in 2025. Trend: 2023 $325 · 2024 $435 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $102 |
| Amgen Inc. | 1 | $97 |
| UCB, Inc. | 2 | $96 |
| Organon LLC | 6 | $47 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $20 |
Products named: Otezla, Bimzelx, SKYRIZI, RINVOQ, ILUMYA, VTAMA, TREMFYA, NEMLUVIO.
Industry payments across NC — which companies pay providers there.
